Infantile pyloric stenosis: forceful vomiting, diagnosis, surgery and recovery

Infantile hypertrophic pyloric stenosis is a narrowing of the stomach outlet caused by thickening of its muscle. Progressively forceful vomiting in a young baby needs urgent assessment. Hospital care corrects dehydration and salt disturbances before an operation called pyloromyotomy. CUH parent information. Confidence: moderate for this clinical-care outline; this review does not establish an independently financed comparison of surgical techniques or a supplement treatment.

Key takeaways
  • Persistent or increasingly forceful vomiting should not be dismissed as ordinary spit-up.
  • Green or yellow-green vomit can indicate a different intestinal obstruction and needs emergency care.
  • Blood tests and hydration assessment help make an operation safer; stabilization comes first.
  • Feeding, pain relief and discharge instructions belong to the baby’s treating team.
  • Public or hospital guidance explains care without clearing the funding of every supporting study.

Table of contents

Evidence summary

Clinical guidance, human outcome research and funding independence answer different questions. The guidance below explains care; it does not independently reproduce the trials behind a medicine or supplement.

Claim / interventionEvidence reviewedFunding / conflictsInterpretation / limits
Progressive infant vomitingNICE final recommendations and specialist provider originalsInstitutional/provider context; full source-trial finances unclassifiedSame-day assessment for the specified young-infant presentation; age is not a safety gate.
Green/yellow-green vomitNational child-vomiting safetyPublic institutional contextEmergency assessment for possible other obstruction.
Preoperative hydrationCUH and NNUH care pathwaysProvider context; not a cleared comparative trialCorrect fluid/salt disturbance before surgery; no home fluid/fasting regimen.
PyloromyotomyProvider operation/consent informationTechnique trial and equipment chains unclosedStandard-care outline, no superiority percentage or guarantee.
SupplementsNo eligible independent replacement establishedPediatric safety synthesis is dated; product trials unclassifiedDo not substitute an unproven product for assessment.

What infantile pyloric stenosis means

The pylorus is the outlet where the stomach meets the small intestine. In this condition its muscle becomes unusually thick, reducing the opening through which milk passes. The name describes a mechanical narrowing, rather than simply excess stomach acid. GOSH explanation.

Symptoms typically emerge in the early weeks of infancy and can develop gradually. A baby may bring up increasingly forceful vomit yet remain hungry afterward. Family history can be relevant, but the exact cause is not settled. A typical age or family pattern does not diagnose an individual. Presentation and family context.

Use the full name when asking about a suspected diagnosis. Ordinary infant reflux, infantile pyloric stenosis and adult gastric-outlet obstruction have different assessment pathways. A guide written for an adult with an ulcer or cancer cannot supply an infant feeding or surgical plan.

Why obstruction causes vomiting, dehydration and abnormal salts

Milk cannot move easily through the narrowed outlet. Repeated loss of stomach contents can deplete fluid and disturb blood salts and acid–base balance. Hospital clinicians assess those disturbances because they affect readiness for anesthesia and surgery. Professional stabilization guidance.

The severity of a vomit is only part of the assessment. Growth, feeding history, wet nappies and the baby’s general condition matter. A child who still wants milk can nevertheless be losing fluid. GOSH describes fewer wet nappies, weight change and other signs of dehydration. Hydration and feeding pattern.

Tell the team what changed and when, without trying to demonstrate a projectile episode or provoke vomiting with another feed. If photographs or records are already available, they may help explain the history; documenting symptoms must not delay assessment.

Diagnosis: examination, ultrasound and blood tests

Assessment includes the feeding/vomiting history and examination. Clinicians may use ultrasound to assess the pylorus and blood tests to measure the consequences of vomiting. A parent should not try to diagnose a muscle lump or interpret a single measurement without the pediatric team. Parent diagnostic information.

An inconclusive scan can require clinical reassessment and sometimes repeat imaging. The 2022 professional pathway also considers other explanations, including infection or reflux. Its local timing and blood thresholds are not a home decision rule and are not copied into this article. Differential diagnosis and imaging context.

NICE recommends same-day specialist hospital assessment for infants younger than two months with progressive or forceful vomiting of feeds. This identifies a particularly important presentation; it does not make forceful vomiting safe in an older infant. Final NG1 recommendation 1.1.19.

Ask what the examination, scan and laboratory results establish, and what remains uncertain. If the diagnosis changes, request an explanation of the alternative and a clear plan for returning if the baby deteriorates. An initially reassuring result does not replace follow-up instructions.

Feeding and supplements while a baby is being assessed

Do not start an internet fasting schedule, replace milk with water or dilute formula to manage suspected obstruction. Ask the urgent-care team for immediate feeding instructions. In hospital, the team decides when milk should be withheld or restarted and how fluid needs will be met. Hospital preparation and feeding care.

Effortless milk regurgitation can occur with reflux, but projectile vomiting, feeding refusal, swelling or tenderness, and dehydration deserve review. Ordinary reflux advice cannot establish that a progressively vomiting infant is safe to manage at home. Reflux and warning signs.

No independently verified probiotic, herb, digestive enzyme or vitamin replacement for pyloric care was established in this review. NCCIH advises against delaying conventional care for unproven products and recommends telling the child’s clinicians about all complementary approaches. Bring packaging for anything already given. Pediatric product safety.

Pyloromyotomy, surgical choices and the evidence boundary

The usual operation is pyloromyotomy: the surgeon divides the thickened muscle to widen the outlet. It may be performed through a small open incision or using keyhole surgery. The team explains the planned approach and obtains consent. Operation and consent explanation.

This review uses provider guidance to describe standard care. It does not label one technique independently superior: comparative trials, equipment relationships and author finances were not fully screened here. A hospital’s experience and an individual infant’s circumstances belong in that discussion.

Ask why the proposed approach suits this baby, whether another approach might be needed during the operation, and who will explain any change afterward. Do not interpret a keyhole label as a guarantee of no complications or an open approach as evidence that care is outdated.

The operation addresses the outlet narrowing. It is not removal of the whole stomach, and treatment of an unrelated infection or reflux problem is a separate question. Ask the surgeon to explain the anatomy in plain language before comparing recovery stories from different procedures. What the operation changes.

Emergency signs: green vomit, dehydration and serious illness

Green or yellow-green vomiting in a child needs emergency assessment. Bilious vomit may indicate intestinal obstruction other than typical pyloric stenosis. Do not wait to see whether it becomes projectile or resolves with a different milk. Age-specific vomiting emergencies.

A baby who is difficult to wake, has serious breathing difficulty, a seizure, or concerning blue, grey or blotchy skin needs emergency help. A temperature of 38°C or higher in a baby under three months needs immediate emergency assessment. These are general infant illness alarms, not symptoms that must all appear together. Current infant emergency guidance.

Fewer wet nappies, unusual sleepiness or a sunken soft spot can accompany dehydration. Cold skin, abnormal breathing or difficult waking can indicate shock. Seek urgent help for deteriorating hydration; do not wait for a specific number of missed nappies. Current dehydration triage.

Blood in vomit, a swollen or tender abdomen, feeding difficulty and faltering growth also require assessment rather than routine reflux reassurance. Tell the clinician about the vomit’s actual color and the baby’s condition; a diagnosis suspected earlier does not explain every new alarm. Separate red-flag assessment.

Medicines, fluids and anesthesia need one coordinated plan

Intravenous fluids and correction of salt disturbances are part of hospital preparation. A tube through the nose into the stomach may be used to drain its contents. These are supervised treatments; an older professional fluid chart is not a recipe for home use. Clinician-only preparation.

Tell the anesthetic and surgical teams about all medicines, supplements, allergies and recent illness. Include the name, concentration and last administration of anything already given, rather than only saying “baby medicine.” The team can reconcile that information with its planned treatment.

Ask for the intended pain-relief plan and whom to contact if it is not controlling discomfort. This guide gives no analgesic quantity, antibiotic course, acid-suppressant regimen or advice to start or stop a prescribed product. Individual postoperative instructions take account of the infant’s current feeding and clinical condition.

Complementary products can have adverse effects or contaminants, and children are not simply small adults. Product disclosure supports coordinated care; a natural label does not establish infant safety. Child-specific safety limits.

Why every persistently vomiting infant needs individual assessment

NICE distinguishes effortless regurgitation in a well infant from increasingly forceful vomiting and other red flags. Feeding concerns or changed responsiveness should lead to reassessment even if reflux was previously suggested. The assessment must address the current baby, not only the earlier diagnostic label. Reassessment after reflux reassurance.

A baby’s apparent hunger or a familiar family story is not enough to exclude illness. Provide the timing of symptoms, feeding type, weight information if known and changes in wet nappies. If more than one person feeds or cares for the baby, combine those observations into one accurate account.

When advice is given over the telephone, make sure the clinician understands whether vomiting is effortless or forceful and whether fluid intake is staying down. Describe uncertainty honestly. Do not describe an infant as well solely because the baby was settled earlier in the day.

Recovery, discharge and returning for persistent vomiting

Vomiting may occur after the operation while feeding is reintroduced. Discharge depends on the baby being well enough and maintaining adequate intake, rather than a universal clock. Persistent or worsening vomiting needs the team’s advice; green vomit or serious illness remains an emergency. Recovery and feeding assessment.

Surgical complications can include wound infection, bleeding, perforation or damage to nearby structures. Ask how concerns would be checked. Increasing wound redness, swelling or discharge should be reported promptly according to the discharge plan. Consent and complication context.

Before leaving hospital, obtain written feeding, wound and medicine instructions plus a contact for evenings or weekends. Check how follow-up and growth review will be arranged. Ask what amount or pattern of vomiting the team expects and which change requires a return.

A recovery story from another infant cannot set a deadline for this child. The useful questions are whether feeds are being retained, hydration is adequate and the baby is recovering as the treating team expects. Record concerns clearly rather than assuming that every postoperative episode is either harmless or a failed operation.

Animal mechanisms and unreviewed remedies cannot establish benefit

A proposed explanation for muscle growth does not prove that a product can safely reverse the narrowing in a baby. Animal and laboratory results are excluded from the clinical-efficacy verdict. Evidence from adult digestive symptoms also cannot establish infant treatment.

This guide establishes a care and safety outline, not a numerical success estimate or an independent ranking of treatments. No eligible supplement replacement was established. Missing financially screened comparative evidence is a limitation of this review, not a reason to delay urgent assessment.

Funding and source roles

Follow the money

Who paid for the evidence?

Follow named sources to the funding and relationships disclosed in this article. Numbered article disclosures preserve notes where a source is not identified. A public or university name alone does not establish independence.

Public / academicCommercial support or tiesUnknown / not disclosed
Disclosed funding & relationshipsOwn 2025–26 accounts trace NHS/private care, research/training, donations and industry/charity partnerships. Leaflet allocation and contributor financial interests unclosed.
Use & limitsB, provisional — approved 8 September 2025, version 9, document 550. Clinical governance aids accuracy; local procedure advice and unclosed author/trial money remain.
Disclosed funding & relationshipsOwn financial review reports majority DHSC grant-in-aid; NHS England/devolved support, appraisal fees, commercial advice and research grants. No individual NG1 source allocation inferred.
Use & limitsB, provisional — original financial text actually read. Public audit aids provenance; paid services/cost remit and absent old guideline-specific allocation remain limits.
Disclosed funding & relationshipsJune 2026 board original reports private care, NIHR, charity, EU and commercial research routes. Own current financial index lists a 13 MB 2025–26 audited report that could not be read; page funding unclosed.
Use & limitsC, provisional — actual clinical body read, no clinical review date identified. Specialist care supports explanation; undated/local advice, latest audited-ledger access and author interests remain gaps.
View 15 more funding disclosures
Disclosed funding & relationshipsOwn audited 2025–26 accounts identify NHS commissioners, private/overseas care, R&D, education/training and grants/donations; research contracts and page/author allocation unclosed.
Use & limitsC, provisional — actual three-page leaflet read. Its review field is malformed (19/08/20204); next review 19 August 2025 has passed. Local consent context helps, but dates, author interests and source-trial finance limit confidence.
Disclosed funding & relationshipsOwn audited 2025–26 accounts identify NHS commissioners, private/overseas care, R&D, education/training and grants/donations; research contracts and page/author allocation unclosed.
Use & limitsC, provisional — approved 18 January 2022, no clinical changes from earlier version; review due 18 January 2025 passed. Actual six pages read; old literature/consensus and unclosed interests remain.
Disclosed funding & relationshipsOwn 2025–26 accounts trace mainly DHSC grant, NHS England support, appraisal/advice fees and research income. Exact 2015/2019 committee and underlying trial interests not financially cleared here.
Use & limitsC, provisional — final recommendations published 14 January 2015, updated 9 October 2019. Relevant original indexed sections read; direct retrieval blocked. Dated evidence, cost remit and incomplete interests remain.
Source / disclosureNHS: reflux in babies
Disclosed funding & relationshipsOwn content policy states DHSC funding, no advertising/corporate sponsorship and clinical checking. Policy is October 2022 with review deadline passed; actual page contributors and underlying trial finances unclosed.
Use & limitsB, provisional — actual body reviewed 10 June 2025 read. Public triage/clinical accountability aids accuracy; simplification, policy age and undisclosed source-trial finances remain.
Disclosed funding & relationshipsOwn content policy states DHSC funding, no advertising/corporate sponsorship and clinical checking. Policy is October 2022 with review deadline passed; actual page contributors and underlying trial finances unclosed.
Use & limitsB, provisional — actual body reviewed 6 August 2026 read. Public triage/clinical accountability aids accuracy; simplification, policy age and undisclosed source-trial finances remain.
Source / disclosureNHS: dehydration
Disclosed funding & relationshipsOwn content policy states DHSC funding, no advertising/corporate sponsorship and clinical checking. Policy is October 2022 with review deadline passed; actual page contributors and underlying trial finances unclosed.
Use & limitsB, provisional — actual body reviewed 1 May 2026 read. Public triage/clinical accountability aids accuracy; simplification, policy age and undisclosed source-trial finances remain.
Source / disclosureNHS: vomiting safety
Disclosed funding & relationshipsOwn content policy states DHSC funding, no advertising/corporate sponsorship and clinical checking. Policy is October 2022 with review deadline passed; actual page contributors and underlying trial finances unclosed.
Use & limitsB, provisional — actual body reviewed 21 December 2023 read. Public triage/clinical accountability aids accuracy; simplification, policy age and undisclosed source-trial finances remain.
Disclosed funding & relationshipsFederal budget documentation identifies public funding; actual contributor and referenced-study backer chains unclosed.
Use & limitsC, provisional — actual March 2017 body/date read. Federal education supports safety questions; dated synthesis and incomplete trial finance limit benefit claims.
Disclosed funding & relationshipsProvider accounts, notes 2.1–2.3: NHS care, private/overseas income, research, training and donations. Research section describes NIHR infrastructure and industry/charity partners.
Use & limitsB, provisional — statutory reporting and audit; aggregated service/research income, incomplete named donor and leaflet-payment chain.
Disclosed funding & relationshipsOwn accounts, notes 2.1–3, trace public/private/overseas clinical income, research and training, grants/donations. Charity support for assets appears separately; outgoing donations are not incoming-funding proof.
Use & limitsB, provisional — actual audited original and relevant notes read. Statutory scrutiny supports revenue provenance; exact R&D contract sponsors, author payments and leaflet allocation remain unknown.
Disclosed funding & relationshipsOwn statutory-report index links current and historical reports; no article allocation or full research-contract schedule supplied by the index.
Use & limitsB, provisional for directly listed document/location facts; an index alone is not a complete financial audit.
Disclosed funding & relationshipsOwn board papers report private-care income and NIHR, charity, EU, commercial and nonprofit research routes. 2025–26 R&D figures explicitly not yet validated; no totals reproduced.
Use & limitsC, provisional — actual selected financial/research sections read, including attachment C printed page 47/PDF page 65. Management reporting supports route tracing, not an audited ledger or page-specific payment.
Disclosed funding & relationshipsLists 2025–26 audited annual report/accounts, size 13 MB. Full report exceeded retrieval limit; alternative local retrieval failed. Current board paper is a separate management source.
Use & limitsB, provisional for listed reporting/location; newest full audited ledger and page allocations unreviewed.
Disclosed funding & relationshipsStates DHSC website funding, no advertising/corporate sponsorship, and staff/external interest disclosure requirements. Actual individual declarations and page spending not published here.
Use & limitsC, provisional — reviewed 14 October 2022, due 14 October 2025 passed. Explicit process/funding statements aid traceability; aged process wording and no payment ledger limit assurance.
Disclosed funding & relationshipsNIH/HHS federal congressional-budget documentation. Requested-year budgets and institutional priorities do not establish the finance of every cited supplement trial.
Use & limitsB, provisional — traceable government-budget process; an older fiscal document and incomplete page/trial donor chain.

This graphic reorganizes the article's disclosures; it is not a new financial audit or independence classification. Highlighted notes show different funding relationships where available. Review funding is separate from underlying trial funding. Disclosure is not proof of falsehood, and no declared conflict is not proof of complete independence.

Provider guidance, national triage advice and financial originals serve different purposes. A current audited report does not refresh a dated clinical document. The GOSH current audited-report access gap and NNUH malformed/passed review dates are explicit. Corporate efficacy is excluded, and supporting trial/contributor finances remain unclassified.

SourceFunding / backersCountry / jurisdictionIndependenceCredibility / incentives / gaps
CUH: September 2025 pyloric information for parentsOwn 2025–26 accounts trace NHS/private care, research/training, donations and industry/charity partnerships. Leaflet allocation and contributor financial interests unclosed.United Kingdom; Cambridge University Hospitals, Hills Road, Cambridge.Tier 2 provider context, provisional; supporting trial independence unclassified.B, provisional — approved 8 September 2025, version 9, document 550. Clinical governance aids accuracy; local procedure advice and unclosed author/trial money remain.
GOSH: own pyloric stenosis originalJune 2026 board original reports private care, NIHR, charity, EU and commercial research routes. Own current financial index lists a 13 MB 2025–26 audited report that could not be read; page funding unclosed.United Kingdom; Great Ormond Street Hospital for Children NHS Foundation Trust, Great Ormond Street, London WC1N 3JH; not its separate charity.Tier 2 provider context, provisional.C, provisional — actual clinical body read, no clinical review date identified. Specialist care supports explanation; undated/local advice, latest audited-ledger access and author interests remain gaps.
NNUH: pyloric stenosis parent leaflet, version 6Own audited 2025–26 accounts identify NHS commissioners, private/overseas care, R&D, education/training and grants/donations; research contracts and page/author allocation unclosed.United Kingdom; Norfolk and Norwich University Hospitals NHS Foundation Trust, Colney Lane, Norwich NR4 7UY.Tier 2 provider context, provisional.C, provisional — actual three-page leaflet read. Its review field is malformed (19/08/20204); next review 19 August 2025 has passed. Local consent context helps, but dates, author interests and source-trial finance limit confidence.
NNUH: 2022 professional projectile-vomiting guidanceOwn audited 2025–26 accounts identify NHS commissioners, private/overseas care, R&D, education/training and grants/donations; research contracts and page/author allocation unclosed.United Kingdom; Norfolk and Norwich University Hospitals, Norwich. Named authors/approvers include Khizer Mansoor and Milind Kulkarni.Tier 2 provider guidance, provisional; full contributor/trial financial chain unclassified.C, provisional — approved 18 January 2022, no clinical changes from earlier version; review due 18 January 2025 passed. Actual six pages read; old literature/consensus and unclosed interests remain.
NICE NG1: final pediatric reflux recommendationsOwn 2025–26 accounts trace mainly DHSC grant, NHS England support, appraisal/advice fees and research income. Exact 2015/2019 committee and underlying trial interests not financially cleared here.United Kingdom; NICE nondepartmental public body; 2026 accounts contact 3 Piccadilly Place, Manchester, with London operations.Tier 2 institution, provisional; supporting efficacy trials unclassified.C, provisional — final recommendations published 14 January 2015, updated 9 October 2019. Relevant original indexed sections read; direct retrieval blocked. Dated evidence, cost remit and incomplete interests remain.
NHS: reflux in babiesOwn content policy states DHSC funding, no advertising/corporate sponsorship and clinical checking. Policy is October 2022 with review deadline passed; actual page contributors and underlying trial finances unclosed.United Kingdom; national NHS website/England health education; source is not the separate hospital trusts.Tier 1 public institutional context, provisional; complete page/trial independence unclassified.B, provisional — actual body reviewed 10 June 2025 read. Public triage/clinical accountability aids accuracy; simplification, policy age and undisclosed source-trial finances remain.
NHS: urgent medical help under fiveOwn content policy states DHSC funding, no advertising/corporate sponsorship and clinical checking. Policy is October 2022 with review deadline passed; actual page contributors and underlying trial finances unclosed.United Kingdom; national NHS website/England health education; source is not the separate hospital trusts.Tier 1 public institutional context, provisional; complete page/trial independence unclassified.B, provisional — actual body reviewed 6 August 2026 read. Public triage/clinical accountability aids accuracy; simplification, policy age and undisclosed source-trial finances remain.
NHS: dehydrationOwn content policy states DHSC funding, no advertising/corporate sponsorship and clinical checking. Policy is October 2022 with review deadline passed; actual page contributors and underlying trial finances unclosed.United Kingdom; national NHS website/England health education; source is not the separate hospital trusts.Tier 1 public institutional context, provisional; complete page/trial independence unclassified.B, provisional — actual body reviewed 1 May 2026 read. Public triage/clinical accountability aids accuracy; simplification, policy age and undisclosed source-trial finances remain.
NHS: vomiting safetyOwn content policy states DHSC funding, no advertising/corporate sponsorship and clinical checking. Policy is October 2022 with review deadline passed; actual page contributors and underlying trial finances unclosed.United Kingdom; national NHS website/England health education; source is not the separate hospital trusts.Tier 1 public institutional context, provisional; complete page/trial independence unclassified.B, provisional — actual body reviewed 21 December 2023 read. Public triage/clinical accountability aids accuracy; simplification, policy age and undisclosed source-trial finances remain.
NCCIH: March 2017 complementary approaches in childrenFederal budget documentation identifies public funding; actual contributor and referenced-study backer chains unclosed.United States; NIH/NCCIH, Bethesda, Maryland.Tier 1 institution, provisional; supporting studies unclassified.C, provisional — actual March 2017 body/date read. Federal education supports safety questions; dated synthesis and incomplete trial finance limit benefit claims.
CUH: own 2025–2026 accountsProvider accounts, notes 2.1–2.3: NHS care, private/overseas income, research, training and donations. Research section describes NIHR infrastructure and industry/charity partners.United Kingdom; Cambridge NHS Foundation Trust.Tier 3 financial self-report context.B, provisional — statutory reporting and audit; aggregated service/research income, incomplete named donor and leaflet-payment chain.
NNUH: audited 2025–26 annual report and accountsOwn accounts, notes 2.1–3, trace public/private/overseas clinical income, research and training, grants/donations. Charity support for assets appears separately; outgoing donations are not incoming-funding proof.United Kingdom; Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich; actual 186-page original.Tier 3 institutional financial disclosure.B, provisional — actual audited original and relevant notes read. Statutory scrutiny supports revenue provenance; exact R&D contract sponsors, author payments and leaflet allocation remain unknown.
NNUH: own annual-report indexOwn statutory-report index links current and historical reports; no article allocation or full research-contract schedule supplied by the index.United Kingdom; actual index footer gives Colney Lane, Norwich NR4 7UY.Tier 3 institutional self-disclosure.B, provisional for directly listed document/location facts; an index alone is not a complete financial audit.
GOSH: 18 June 2026 public board papersOwn board papers report private-care income and NIHR, charity, EU, commercial and nonprofit research routes. 2025–26 R&D figures explicitly not yet validated; no totals reproduced.United Kingdom; Great Ormond Street Hospital for Children NHS Foundation Trust, London; public 178-page original.Tier 3 institutional management financial disclosure.C, provisional — actual selected financial/research sections read, including attachment C printed page 47/PDF page 65. Management reporting supports route tracing, not an audited ledger or page-specific payment.
GOSH: July 2026 own audited-report indexLists 2025–26 audited annual report/accounts, size 13 MB. Full report exceeded retrieval limit; alternative local retrieval failed. Current board paper is a separate management source.United Kingdom; hospital trust, London; actual 24 July 2026 index and footer read.Tier 3 institutional financial self-disclosure.B, provisional for listed reporting/location; newest full audited ledger and page allocations unreviewed.
NICE: audited 2025–26 annual accountsOwn financial review reports majority DHSC grant-in-aid; NHS England/devolved support, appraisal fees, commercial advice and research grants. No individual NG1 source allocation inferred.United Kingdom; public body, Manchester/London; report printed 7 July 2026.Tier 3 institutional financial disclosure.B, provisional — original financial text actually read. Public audit aids provenance; paid services/cost remit and absent old guideline-specific allocation remain limits.
NHS: own October 2022 content/funding policyStates DHSC website funding, no advertising/corporate sponsorship, and staff/external interest disclosure requirements. Actual individual declarations and page spending not published here.United Kingdom; national website editorial policy; historical organizational naming not asserted as current 2026 structure.Tier 3 institutional policy self-disclosure.C, provisional — reviewed 14 October 2022, due 14 October 2025 passed. Explicit process/funding statements aid traceability; aged process wording and no payment ledger limit assurance.
NCCIH: own congressional-budget documentNIH/HHS federal congressional-budget documentation. Requested-year budgets and institutional priorities do not establish the finance of every cited supplement trial.United States; NCCIH, Bethesda, Maryland.Tier 1 public institution; budget self-report context.B, provisional — traceable government-budget process; an older fiscal document and incomplete page/trial donor chain.

Frequently asked questions

Is pyloric stenosis the same as ordinary reflux?

No. It involves a narrowed stomach outlet. Progressive forceful vomiting warrants reassessment rather than routine spit-up reassurance.

Why do doctors correct dehydration before the operation?

Vomiting can disturb fluid and blood salts. The hospital corrects those problems and assesses readiness for anesthesia.

Does green vomit fit the usual pattern?

Green or yellow-green vomit can indicate a different intestinal obstruction. Seek emergency assessment.

Can a probiotic or herbal remedy replace hospital care?

An independent replacement was not established here. Do not delay assessment for an unproven product.

Does any vomiting after pyloromyotomy mean the operation failed?

No. Some vomiting can occur during recovery, but persistent, worsening or alarming symptoms need clinical review. Follow the infant’s discharge instructions.

Sources and funding notes

Originals checked 4 October 2026. CUH parent information was approved 8 September 2025; GOSH clinical page is undated. NNUH parent leaflet has malformed review text and an August 2025 deadline passed; its professional pathway was approved January 2022, reviewed with no clinical changes, and due January 2025. Old wait windows, ranitidine/fluid/feeding regimens and blanket nonemergency statements are not adopted. NICE NG1 is final 2015 guidance updated October 2019, read in relevant original indexed sections after direct access failed, not a 2026 update or consultation draft. Current NHS clinical dates and dated October 2022 content policy are separated. GOSH June 2026 board reports were read, with unvalidated R&D figures; its listed 13 MB newest audited report could not be retrieved. NNUH/CUH own current audited revenue notes and NICE original 2025–26 financial text were read. NCCIH pediatric synthesis is March 2017. Financial provenance does not establish the benefit of every supporting trial.

  1. CUH: September 2025 pyloric information for parents — Definition, preoperative stabilization, pyloromyotomy and postoperative review; no fixed recovery time or personal feeding/pain regimen.
  2. GOSH: own pyloric stenosis original — Progressive vomiting and hydration, muscle thickening and hospital assessment. Blanket no-alternative, fixed timing, fever/pain instructions and recovery guarantees are not adopted.
  3. NNUH: pyloric stenosis parent leaflet, version 6 — Examination, ultrasound/blood tests, surgery and uncommon complication roles; no old NHS Direct contact or discharge timetable.
  4. NNUH: 2022 professional projectile-vomiting guidance — Blood/electrolyte assessment, differential diagnosis and stabilization before operation. Fluid doses, blood thresholds, wait windows, blanket nonemergency wording and ranitidine advice excluded.
  5. NICE NG1: final pediatric reflux recommendations — Same-day specialist assessment for progressive/forceful vomiting in young infants and separate bilious-vomiting obstruction warning. Not a current drug/feeding protocol or consultation draft.
  6. NHS: reflux in babies — Effortless reflux distinction, feeding alarms and flat-back sleep advice; no reflux medicine/feeding regimen for suspected obstruction.
  7. NHS: urgent medical help under five — General infant illness alarms, including abnormal responsiveness, breathing and serious fever; no home observation deadline.
  8. NHS: dehydration — Reduced wet nappies, drowsiness and shock signs; generic oral-rehydration/continued-feeding instructions not applied to obstructed infants.
  9. NHS: vomiting safety — Green/yellow-green vomit in children requires emergency assessment; no assumption that all vomiting is pyloric stenosis.
  10. NCCIH: March 2017 complementary approaches in children — Product disclosure and avoiding delayed conventional care only; no infant pyloric remedy, technique endorsement or current numerical safety estimate.
  11. CUH: own 2025–2026 accounts — Actually opened 197-page 2025–26 original; selected revenue/partnership notes, not individual leaflet funding.
  12. NNUH: audited 2025–26 annual report and accounts — Provider-specific finance, not national NHS website money and not proof that every clinical study is independent.
  13. NNUH: own annual-report index — Current report route and provider identity only; the linked current accounts were separately opened.
  14. GOSH: 18 June 2026 public board papers — Identifies documented mixed revenue routes; no extrapolation from unrelated GOSH-sponsored trials to this pyloric leaflet.
  15. GOSH: July 2026 own audited-report index — Explicit access gap; no claim to have read the newest accounts or its complete donor/contract ledger.
  16. NICE: audited 2025–26 annual accounts — Institution revenue and current contact provenance only; current financial accounts do not refresh 2019 clinical guidance.
  17. NHS: own October 2022 content/funding policy — Website-specific funding/editorial route, not hospital trust accounts and not independent verification of supporting trials.
  18. NCCIH: own congressional-budget document — Public federal research-budget route; no claim that all underlying pediatric studies lack commercial ties.

Educational information reviewed 4 October 2026. This guide supports an informed clinical discussion; it does not diagnose an individual or provide a personal treatment regimen.

Have a question — or want us to cover something?

Ask about anything on this page, or request the next deep dive: an ingredient, a supplement, or a health concern. We use published research, evidence syntheses, and regulatory guidance, with clear source links.

We store your topic, message, optional email, and this page so we can manage and reply to the request. Do not include diagnoses, medications, or other sensitive medical information. See our Privacy Policy.